Dianthus Therapeutics | MGTA - Ebit

Prix De L'Action
87.39
Variation Quotidienne
-2.43 -2.71%
Mensuellement
9.77%
Annuel
303.28%
Q2 Prévisions
85.52




Ebit Changement Date
Akebia Therapeutics USD -5.45M 9.4M 2025-12
Alaunos Therapeutics USD -1.19M 148K 2025-09
Avita Medical AUD -10.39M 1.72M 2025-12
Celltrion KRW 301.04B 58.57B 2025-09
Cspc Pharmaceutical CNY 206.26M 1.02B 2025-12
Deva Holding AS TRY 820.88M 192.13M 2023-09
Dianthus Therapeutics USD -69.54M 29.25M 2025-12
Divis Laboratories Ltd INR 7.72B 30M 2025-12
IQVIA Holdings USD 2.68B 2.1B 2025-12
Kangmei Pharma CNY -26.7M 43.13M 2025-09
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Laboratorios Farma EUR 135.05M 49.84M 2023-12
Malin Corporation EUR -1.1M 300K 2024-12
Medical Developments International AUD -36K 12.96M 2025-12
Moderna USD -857M 597M 2025-12
Neuren Pharmaceuticals AUD 17.01M 154.09M 2025-12
Organigram Holdings CAD -20.13M 7.92M 2025-12
Organon & Co USD 388M 28M 2025-09
Ovoca Bio EUR -1.16M 4.48M 2025-06
Pharma Mar EUR 43.61M 47.57M 2025-12
Qiagen NV USD 121.88M 19.18M 2025-12
Revvity USD 145.83M 47.49M 2025-12
Sartorius EUR 160.7M 94.1M 2026-03
Sino Biopharmaceutical CNY 5.18B 3.32B 2025-06
Tectonic Therapeutic USD -21.52M 374K 2025-12
Tilray USD -20.01M 9.34M 2025-09
Viatris USD -157.5M 392M 2025-12
Xeris Pharmaceuticals USD 16.77M 8.88M 2025-12
Zealand Pharma A/S -707.05M 245.73M 2025-12
Zz Pientze Pharmaceu CNY 501.33M 15.6M 2025-09